Objective:To analyze the efficacy of the modified vertical superomedial five-flap reductive mammoplasty in patients with macromastia.Methods:A total of 31 female patients (62 breasts) with moderate-to-severe macromastia, aged 18-45 (36±6) years, were retrospectively included in the Department of Plastic Surgery, Sichuan Provincial People′s Hospital from October 2021 to October 2023. All patients underwent the modified vertical superomedial five-flap technique for breast reduction. Postoperative follow-up lasted for one year. Scar status was evaluated using the Vancouver scar scale (VSS), while patient satisfaction and breast morphology were assessed with the Chinese version of the Breast-Q questionnaire and the breast morphology score. Postoperative improvements in areolar diameter, nipple-to-inframammary fold midpoint distance, and nipple-to-suprasternal notch distance were compared with preoperative measurements. Adverse events, including sensory abnormalities and hypertrophic scarring, were recorded.Results:All patients were subject to follow-up, with restored breast fullness and natural contour. At the final follow-up, significant reductions were observed in bilateral areolar diameter, nipple-to-inframammary fold midpoint distance, and nipple-to-suprasternal notch distance compared to preoperative values (all P<0.001). The VSS score was (4.1±1.4) scores, and the breast morphology score was (79.9±2.5) scores. Scores from the Breast-Q questionnaire included satisfaction with breasts (81.6±2.5) scores, psychosocial well-being (83.6±5.2) scores, and sexual well-being (82.5±5.5) scores. Mild hypesthesia of the nipple-areola complex occurred in 2 patients and resolved spontaneously within 6 months postoperatively. Three patients developed mild hypertrophic scarring, which was effectively controlled with topical pharmacotherapy and physical therapy. Conclusion:The modified vertical superomedial five-flap technique is a safe and effective method for breast reduction in patients with macromastia.

Objective:To analyze the efficacy of the modified vertical superomedial five-flap reductive mammoplasty in patients with macromastia.Methods:A total of 31 female patients (62 breasts) with moderate-to-severe macromastia, aged 18-45 (36±6) years, were retrospectively included in the Department of Plastic Surgery, Sichuan Provincial People′s Hospital from October 2021 to October 2023. All patients underwent the modified vertical superomedial five-flap technique for breast reduction. Postoperative follow-up lasted for one year. Scar status was evaluated using the Vancouver scar scale (VSS), while patient satisfaction and breast morphology were assessed with the Chinese version of the Breast-Q questionnaire and the breast morphology score. Postoperative improvements in areolar diameter, nipple-to-inframammary fold midpoint distance, and nipple-to-suprasternal notch distance were compared with preoperative measurements. Adverse events, including sensory abnormalities and hypertrophic scarring, were recorded.Results:All patients were subject to follow-up, with restored breast fullness and natural contour. At the final follow-up, significant reductions were observed in bilateral areolar diameter, nipple-to-inframammary fold midpoint distance, and nipple-to-suprasternal notch distance compared to preoperative values (all P<0.001). The VSS score was (4.1±1.4) scores, and the breast morphology score was (79.9±2.5) scores. Scores from the Breast-Q questionnaire included satisfaction with breasts (81.6±2.5) scores, psychosocial well-being (83.6±5.2) scores, and sexual well-being (82.5±5.5) scores. Mild hypesthesia of the nipple-areola complex occurred in 2 patients and resolved spontaneously within 6 months postoperatively. Three patients developed mild hypertrophic scarring, which was effectively controlled with topical pharmacotherapy and physical therapy. Conclusion:The modified vertical superomedial five-flap technique is a safe and effective method for breast reduction in patients with macromastia.